Home > > > > Report Detail

Global Recombinant Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 132

Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.

These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.

Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.

Scope of the Report:

This report focuses on the Recombinant Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.

The worldwide market for Recombinant Vaccines is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 1260 million US$ in 2023, from 880 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Merck & Co., Inc

- Green Cross Corporation

- Pfizer Inc.

- Bayer AG

- Sanofi S A.

- Protein Science Corporation

- GlaxoSmithKline Plc.

- Novartis AG

- Bharat Biotech

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Subunit Recombinant Vaccines

- Attenuated Recombinant Vaccines

- Vector Recombinant Vaccines

Market Segment by Applications, can be divided into

- Recombinant Human Vaccines

- Animal Recombinant Vaccines

There are 15 Chapters to deeply display the global Recombinant Vaccines market.

Chapter 1, to describe Recombinant Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Recombinant Vaccines, with sales, revenue, and price of Recombinant Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Recombinant Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Recombinant Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Recombinant Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Recombinant Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Recombinant Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Subunit Recombinant Vaccines
1.2.2 Attenuated Recombinant Vaccines
1.2.3 Vector Recombinant Vaccines
1.3 Market Analysis by Applications
1.3.1 Recombinant Human Vaccines
1.3.2 Animal Recombinant Vaccines
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc
2.1.1 Business Overview
2.1.2 Recombinant Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Green Cross Corporation
2.2.1 Business Overview
2.2.2 Recombinant Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Green Cross Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Recombinant Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer AG
2.4.1 Business Overview
2.4.2 Recombinant Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi S A.
2.5.1 Business Overview
2.5.2 Recombinant Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi S A. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Protein Science Corporation
2.6.1 Business Overview
2.6.2 Recombinant Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Protein Science Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline Plc.
2.7.1 Business Overview
2.7.2 Recombinant Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis AG
2.8.1 Business Overview
2.8.2 Recombinant Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bharat Biotech
2.9.1 Business Overview
2.9.2 Recombinant Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bharat Biotech Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Recombinant Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Recombinant Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Recombinant Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Recombinant Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Recombinant Vaccines Market Analysis by Regions
4.1 Global Recombinant Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Recombinant Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Recombinant Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Recombinant Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Recombinant Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Recombinant Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Recombinant Vaccines Sales and Growth Rate (2013-2018)
5 North America Recombinant Vaccines by Countries
5.1 North America Recombinant Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Recombinant Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Recombinant Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Recombinant Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Recombinant Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Recombinant Vaccines Sales and Growth Rate (2013-2018)
6 Europe Recombinant Vaccines by Countries
6.1 Europe Recombinant Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Recombinant Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Recombinant Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Recombinant Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Recombinant Vaccines Sales and Growth Rate (2013-2018)
6.4 France Recombinant Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Recombinant Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Recombinant Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Recombinant Vaccines by Countries
7.1 Asia-Pacific Recombinant Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Recombinant Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Recombinant Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Recombinant Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Recombinant Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Recombinant Vaccines Sales and Growth Rate (2013-2018)
7.5 India Recombinant Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Recombinant Vaccines Sales and Growth Rate (2013-2018)
8 South America Recombinant Vaccines by Countries
8.1 South America Recombinant Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Recombinant Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Recombinant Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Recombinant Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Recombinant Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Recombinant Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Recombinant Vaccines by Countries
9.1 Middle East and Africa Recombinant Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Recombinant Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Recombinant Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Recombinant Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Recombinant Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Recombinant Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Recombinant Vaccines Sales and Growth Rate (2013-2018)
10 Global Recombinant Vaccines Market Segment by Type
10.1 Global Recombinant Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Recombinant Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Recombinant Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Subunit Recombinant Vaccines Sales Growth and Price
10.2.1 Global Subunit Recombinant Vaccines Sales Growth (2013-2018)
10.2.2 Global Subunit Recombinant Vaccines Price (2013-2018)
10.3 Attenuated Recombinant Vaccines Sales Growth and Price
10.3.1 Global Attenuated Recombinant Vaccines Sales Growth (2013-2018)
10.3.2 Global Attenuated Recombinant Vaccines Price (2013-2018)
10.4 Vector Recombinant Vaccines Sales Growth and Price
10.4.1 Global Vector Recombinant Vaccines Sales Growth (2013-2018)
10.4.2 Global Vector Recombinant Vaccines Price (2013-2018)
11 Global Recombinant Vaccines Market Segment by Application
11.1 Global Recombinant Vaccines Sales Market Share by Application (2013-2018)
11.2 Recombinant Human Vaccines Sales Growth (2013-2018)
11.3 Animal Recombinant Vaccines Sales Growth (2013-2018)
12 Recombinant Vaccines Market Forecast (2018-2023)
12.1 Global Recombinant Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Recombinant Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Recombinant Vaccines Market Forecast (2018-2023)
12.2.2 Europe Recombinant Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Recombinant Vaccines Market Forecast (2018-2023)
12.2.4 South America Recombinant Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Recombinant Vaccines Market Forecast (2018-2023)
12.3 Recombinant Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Recombinant Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Recombinant Vaccines Market Share Forecast by Type (2018-2023)
12.4 Recombinant Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Recombinant Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Recombinant Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Recombinant Vaccines Picture
Table Product Specifications of Recombinant Vaccines
Figure Global Sales Market Share of Recombinant Vaccines by Types in 2017
Table Recombinant Vaccines Types for Major Manufacturers
Figure Subunit Recombinant Vaccines Picture
Figure Attenuated Recombinant Vaccines Picture
Figure Vector Recombinant Vaccines Picture
Figure Recombinant Vaccines Sales Market Share by Applications in 2017
Figure Recombinant Human Vaccines Picture
Figure Animal Recombinant Vaccines Picture
Figure United States Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Recombinant Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc Recombinant Vaccines Type and Applications
Table Merck & Co., Inc Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table Green Cross Corporation Recombinant Vaccines Type and Applications
Table Green Cross Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Recombinant Vaccines Type and Applications
Table Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Recombinant Vaccines Type and Applications
Table Bayer AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi S A. Basic Information, Manufacturing Base and Competitors
Table Sanofi S A. Recombinant Vaccines Type and Applications
Table Sanofi S A. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Protein Science Corporation Basic Information, Manufacturing Base and Competitors
Table Protein Science Corporation Recombinant Vaccines Type and Applications
Table Protein Science Corporation Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Plc. Recombinant Vaccines Type and Applications
Table GlaxoSmithKline Plc. Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Recombinant Vaccines Type and Applications
Table Novartis AG Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table Bharat Biotech Recombinant Vaccines Type and Applications
Table Bharat Biotech Recombinant Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Recombinant Vaccines Sales by Manufacturer (2016-2017)
Figure Global Recombinant Vaccines Sales Market Share by Manufacturer in 2016
Figure Global Recombinant Vaccines Sales Market Share by Manufacturer in 2017
Table Global Recombinant Vaccines Revenue by Manufacturer (2016-2017)
Figure Global Recombinant Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global Recombinant Vaccines Revenue Market Share by Manufacturer in 2017
Figure Top 3 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Global Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table Global Recombinant Vaccines Sales by Regions (2013-2018)
Table Global Recombinant Vaccines Sales Market Share by Regions (2013-2018)
Table Global Recombinant Vaccines Revenue by Regions (2013-2018)
Figure Global Recombinant Vaccines Revenue Market Share by Regions in 2013
Figure Global Recombinant Vaccines Revenue Market Share by Regions in 2017
Figure North America Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure South America Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure North America Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table North America Recombinant Vaccines Sales by Countries (2013-2018)
Table North America Recombinant Vaccines Sales Market Share by Countries (2013-2018)
Figure North America Recombinant Vaccines Sales Market Share by Countries in 2013
Figure North America Recombinant Vaccines Sales Market Share by Countries in 2017
Table North America Recombinant Vaccines Revenue by Countries (2013-2018)
Table North America Recombinant Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America Recombinant Vaccines Revenue Market Share by Countries in 2013
Figure North America Recombinant Vaccines Revenue Market Share by Countries in 2017
Figure United States Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Canada Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table Europe Recombinant Vaccines Sales by Countries (2013-2018)
Table Europe Recombinant Vaccines Sales Market Share by Countries (2013-2018)
Table Europe Recombinant Vaccines Revenue by Countries (2013-2018)
Figure Europe Recombinant Vaccines Revenue Market Share by Countries in 2016
Figure Europe Recombinant Vaccines Revenue Market Share by Countries in 2017
Figure Germany Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure UK Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure France Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Russia Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Italy Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Recombinant Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific Recombinant Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Recombinant Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific Recombinant Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific Recombinant Vaccines Revenue Market Share by Countries 2017
Figure China Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Japan Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Korea Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure India Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure South America Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table South America Recombinant Vaccines Sales by Countries (2013-2018)
Table South America Recombinant Vaccines Sales Market Share by Countries (2013-2018)
Figure South America Recombinant Vaccines Sales Market Share by Countries in 2017
Table South America Recombinant Vaccines Revenue by Countries (2013-2018)
Table South America Recombinant Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America Recombinant Vaccines Revenue Market Share by Countries in 2017
Figure Brazil Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Recombinant Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Recombinant Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa Recombinant Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Recombinant Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa Recombinant Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa Recombinant Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure UAE Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria Recombinant Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa Recombinant Vaccines Sales and Growth Rate (2013-2018)
Table Global Recombinant Vaccines Sales by Type (2013-2018)
Table Global Recombinant Vaccines Sales Share by Type (2013-2018)
Table Global Recombinant Vaccines Revenue by Type (2013-2018)
Table Global Recombinant Vaccines Revenue Share by Type (2013-2018)
Figure Global Subunit Recombinant Vaccines Sales Growth (2013-2018)
Figure Global Subunit Recombinant Vaccines Price (2013-2018)
Figure Global Attenuated Recombinant Vaccines Sales Growth (2013-2018)
Figure Global Attenuated Recombinant Vaccines Price (2013-2018)
Figure Global Vector Recombinant Vaccines Sales Growth (2013-2018)
Figure Global Vector Recombinant Vaccines Price (2013-2018)
Table Global Recombinant Vaccines Sales by Application (2013-2018)
Table Global Recombinant Vaccines Sales Share by Application (2013-2018)
Figure Global Animal Recombinant Vaccines Sales Growth (2013-2018)
Figure Global Recombinant Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global Recombinant Vaccines Sales Forecast by Regions (2018-2023)
Table Global Recombinant Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales Recombinant Vaccines Market Forecast (2018-2023)
Figure Europe Sales Recombinant Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales Recombinant Vaccines Market Forecast (2018-2023)
Figure South America Sales Recombinant Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales Recombinant Vaccines Market Forecast (2018-2023)
Table Global Recombinant Vaccines Sales Forecast by Type (2018-2023)
Table Global Recombinant Vaccines Market Share Forecast by Type (2018-2023)
Table Global Recombinant Vaccines Sales Forecast by Application (2018-2023)
Table Global Recombinant Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs